We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Barr Confirms Patent Challenge To J&J's Razadyne ER
Barr Confirms Patent Challenge To J&J's Razadyne ER
July 25, 2006
Barr Laboratories has filed an application with the FDA to market a generic version of Johnson & Johnson’s (J&J) Alzheimer’s drug Razadyne ER.